Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects
Clinical trial NCT02132429 · TERMINATED
Trial details
- NCT number
- NCT02132429
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-10-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.